These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


247 related items for PubMed ID: 10362204

  • 1. Long-term reproducibility of electrophysiologically guided therapy with sotalol in patients with ventricular tachyarrhythmias.
    Mewis C, Kühlkamp V, Mermi J, Bosch RF, Seipel L.
    J Am Coll Cardiol; 1999 Jun; 33(7):1989-95. PubMed ID: 10362204
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of d,l-sotalol in patients with ventricular tachycardia and in survivors of cardiac arrest.
    Haverkamp W, Martinez-Rubio A, Hief C, Lammers A, Mühlenkamp S, Wichter T, Breithardt G, Borggrefe M.
    J Am Coll Cardiol; 1997 Aug; 30(2):487-95. PubMed ID: 9247523
    [Abstract] [Full Text] [Related]

  • 3. Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment.
    Kühlkamp V, Mewis C, Mermi J, Bosch RF, Seipel L.
    J Am Coll Cardiol; 1999 Jan; 33(1):46-52. PubMed ID: 9935007
    [Abstract] [Full Text] [Related]

  • 4. Infarct related artery patency: relation to serial electropharmacological studies and outcome in patients with previous myocardial infarction and ventricular tachyarrhythmias.
    Hoppe UC, Haverkamp W, Breithardt G, Borggrefe M.
    Pacing Clin Electrophysiol; 2000 May; 23(5):854-62. PubMed ID: 10833706
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of sotalol guided by programmed electrical stimulation for sustained ventricular arrhythmias secondary to coronary artery disease.
    Young GD, Kerr CR, Mohama R, Boone J, Yeung-Lai-Wah JA.
    Am J Cardiol; 1994 Apr 01; 73(9):677-82. PubMed ID: 8166065
    [Abstract] [Full Text] [Related]

  • 6. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA, Banchs JE, Depalma S, Young SK, Penny-Peterson ED, Samii SM, Wolbrette DL, Naccarelli GV, Gonzalez MD.
    J Cardiovasc Electrophysiol; 2012 Mar 01; 23(3):296-301. PubMed ID: 21955243
    [Abstract] [Full Text] [Related]

  • 7. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
    Naccarella F, Rolli A, Carboni A, Finardi A, Aurier E, Favaro L, Contini S, Gherli T, Caponi D, Maranga SS, Lepera G, Bartoletti A.
    G Ital Cardiol; 1999 Oct 01; 29(10):1142-56. PubMed ID: 10546124
    [Abstract] [Full Text] [Related]

  • 8. Acute and chronic antiarrhythmic efficacy of d-sotalol in patients with sustained ventricular tachyarrhythmias.
    Brachmann J, Schöls W, Beyer T, Montero M, Enders B, Kübler W.
    Eur Heart J; 1993 Nov 01; 14 Suppl H():85-7. PubMed ID: 8293757
    [Abstract] [Full Text] [Related]

  • 9. Usefulness of sotalol in suppressing ventricular tachycardia or ventricular fibrillation in patients with healed myocardial infarcts.
    Kuchar DL, Garan H, Venditti FJ, Finkelstein D, Rottman JN, McComb J, McGovern BA, Ruskin JN.
    Am J Cardiol; 1989 Jul 01; 64(1):33-6. PubMed ID: 2741811
    [Abstract] [Full Text] [Related]

  • 10. Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias.
    Nademanee K, Feld G, Hendrickson J, Singh PN, Singh BN.
    Circulation; 1985 Sep 01; 72(3):555-64. PubMed ID: 4017207
    [Abstract] [Full Text] [Related]

  • 11. Effects of sotalol on ventricular tachycardia and fibrillation produced by programmed electrical stimulation: comparison with other antiarrhythmic agents.
    Nademanee K, Singh BN.
    Am J Cardiol; 1990 Jan 02; 65(2):53A-57A; discussion 65A-66A. PubMed ID: 2403735
    [Abstract] [Full Text] [Related]

  • 12. [Antiarrhythmia effectiveness of oral sotalol in patients with coronary heart disease and ventricular tachycardias].
    Trappe HJ, Klein H, Lichtlen PR.
    Z Kardiol; 1987 Oct 02; 76(10):630-4. PubMed ID: 3687165
    [Abstract] [Full Text] [Related]

  • 13. Comparison of d,l-sotalol and implantable defibrillators for treatment of sustained ventricular tachycardia or fibrillation in patients with coronary artery disease.
    Böcker D, Haverkamp W, Block M, Borggrefe M, Hammel D, Breithardt G.
    Circulation; 1996 Jul 15; 94(2):151-7. PubMed ID: 8674173
    [Abstract] [Full Text] [Related]

  • 14. Role of programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and documented sustained ventricular tachyarrhythmias: inducibility and prognostic value in 102 patients.
    Chen X, Shenasa M, Borggrefe M, Block M, Hindricks G, Martinez-Rubio A, Haverkamp W, Willems S, Böcker D, Mäkijärvi M.
    Eur Heart J; 1994 Jan 15; 15(1):76-82. PubMed ID: 8174587
    [Abstract] [Full Text] [Related]

  • 15. Electrophysiologic and antiarrhythmic efficacy of oral sotalol for sustained ventricular tachyarrhythmias: evaluation by programmed stimulation and ambulatory electrocardiogram.
    Steinbeck G, Bach P, Haberl R.
    J Am Coll Cardiol; 1986 Oct 15; 8(4):949-58. PubMed ID: 3760368
    [Abstract] [Full Text] [Related]

  • 16. Clinical usefulness of electrophysiologic testing in patients with ventricular tachycardia and chronic chagasic cardiomyopathy treated with amiodarone or sotalol.
    Leite LR, Fenelon G, Simoes A, Silva GG, Friedman PA, de Paola AA.
    J Cardiovasc Electrophysiol; 2003 Jun 15; 14(6):567-73. PubMed ID: 12875414
    [Abstract] [Full Text] [Related]

  • 17. Randomized crossover comparison of the electrophysiologic and antiarrhythmic efficacy of oral cibenzoline and sotalol for sustained ventricular tachycardia.
    Hoffmann E, Mattke S, Haberl R, Steinbeck G.
    J Cardiovasc Pharmacol; 1993 Jan 15; 21(1):95-100. PubMed ID: 7678686
    [Abstract] [Full Text] [Related]

  • 18. Sotalol in patients with life-threatening ventricular tachyarrhythmias.
    Trappe HJ, Klein H, Lichtlen P.
    Cardiovasc Drugs Ther; 1990 Oct 15; 4(5):1425-32. PubMed ID: 2278875
    [Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of oral sotalol for sustained ventricular tachyarrhythmias refractory to other antiarrhythmic agents.
    Kehoe RF, MacNeil DJ, Zheutlin TA, Ezri MD, Nazari J, Spangenberg RB, Dunnington C, Lueken M.
    Am J Cardiol; 1993 Aug 12; 72(4):56A-66A. PubMed ID: 8346728
    [Abstract] [Full Text] [Related]

  • 20. Potential proarrhythmic effect of biventricular pacing: fact or myth?
    Shukla G, Chaudhry GM, Orlov M, Hoffmeister P, Haffajee C.
    Heart Rhythm; 2005 Sep 12; 2(9):951-6. PubMed ID: 16171749
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.